From July 1, 2020 to September 30, 2020, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 69,714 shares, representing 0.11% for KRW 918.87 million under the buyback announced on March 13, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,685 KRW | +1.51% | +4.88% | -13.11% |
05-20 | HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. | CI |
05-20 | HLB bioStep Co.,Ltd. authorizes a Buyback Plan. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.11% | 166M | |
-38.56% | 8.39B | |
+0.18% | 3.32B | |
+9.29% | 2.48B | |
-18.21% | 2.06B | |
-24.57% | 1.59B | |
+32.37% | 1.15B | |
-7.64% | 704M | |
+8.42% | 678M | |
-29.59% | 508M |
- Stock Market
- Equities
- A278650 Stock
- News HLB bioStep Co.,Ltd.
- Tranche Update on KNOTUS Co.,Ltd's Equity Buyback Plan announced on March 13, 2020.